Southern California University of Health Science
Whittier, California, 90604, United States
NCT Number: NCT00985335
This study intends to test the efficacy of the TheraNeem Lip Therapy balm for Herpes Simplex. The study will include a total of 5 people.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Phase 1
Whittier, California, 90604, United States
Qualified candidates will be officially enrolled into the study within 24 hours of their subsequent outbreak of Herpes Simplex Labialis. They will be given all of the Neem Therapy products to use, and photographs and questionnaires will be taken to assess their progress.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Apply externally 3-4 times per day
Time frame: Baseline and End of Treatment
Southern California University of Health Sciences
Other
Effectiveness of TheraNeem Lip Therapy of Common Symptoms of Herpes Simplex Labialis A Prospective Experimental Case Series (n=5)
Acronym: Neem
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05468619
DNA Virus Infections, Disease
Birmingham, Alabama, United States
View Trial DetailsNCT05298254
Communicable Diseases, DNA Virus Infections
Phoenix, Arizona, United States
View Trial DetailsNCT05989672
DNA Virus Infections, Herpes Simplex
Tokyo, Japan
View Trial DetailsNCT01959295
DNA Virus Infections, Herpes Simplex
Sapporo, Hokkaido, Japan
View Trial Details